Army Drug Development Program. Phase 1. Clinical Testing

Army Drug Development Program. Phase 1. Clinical Testing

This is the final report of contract DAMD17-83-C-3001 under which BIO-MED, Inc. was involved in the following activities: The development of protocols for Phase I Clinical Studies and the administrative and technical processing of these protocols. Analysis, interpretation and reporting of the result...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Reba, Richard C, Barry, Kevin G
Format: Report
Sprache:eng
Schlagworte:
ACETYLCHOLINESTERASE
ANTIMALARIALS
ARMY
BIOASSAY
CLINICAL MEDICINE
DRUGS
MANAGEMENT
PHARMACOKINETICS
Pharmacology
PHASE STUDIES
PROCESSING
TEST AND EVALUATION
WR 194
WR 6026 Antimalarials
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This is the final report of contract DAMD17-83-C-3001 under which BIO-MED, Inc. was involved in the following activities: The development of protocols for Phase I Clinical Studies and the administrative and technical processing of these protocols. Analysis, interpretation and reporting of the results of studies. Keywords: Pharmacokinetics, Anti-Malarials, Pyridostigmine, Abate, WR 194,965, Acetylcholinesterase Assays, WR 6026. Continuation of contract DAMD17-75-C-5036.